AF
GILD icon

Avanza Fonder’s Gilead Sciences GILD Stock Holding History

Avanza Fonder’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18M Buy
142,643
+15,840
+12% +$2.09M 0.39% 42
2026
Q1 		$17.7M Sell
126,803
-4,126
-3% -$578K 0.49% 36
2025
Q4 		$16.1M Buy
130,929
+3,890
+3% +$473K 0.41% 43
2025
Q3 		$14.1M Buy
127,039
+574
+0.5% +$65.2K 0.37% 44
2025
Q2 		$14M Buy
126,465
+6,804
+6% +$724K 0.42% 39
2025
Q1 		$13.4M Sell
119,661
-7,454
-6% -$769K 0.44% 36
2024
Q4 		$11.7M Buy
+127,115
New +$11.4M 0.35% 49

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avanza Fonder's GILD Position: Q2 2026 in Review

Avanza Fonder increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $2.09M and bringing the position to 142,643 shares worth $18M. The position accounts for 0.39% of the portfolio, ranked #42.

Avanza Fonder first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Avanza Fonder held 142,643 shares of Gilead Sciences worth $18M as of Q2 2026.
  • Avanza Fonder bought 15,840 Gilead Sciences shares in Q2 2026, an estimated $2.09M.
  • Gilead Sciences made up 0.39% of Avanza Fonder's portfolio in Q2 2026, its #42 holding.
  • Avanza Fonder first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.